Scarica l'app Stockscreener
2.34
0.43%
-0.01
Precedente Chiudi:
$2.35
Aprire:
$2.37
Volume 24 ore:
711.18K
Relative Volume:
3.11
Capitalizzazione di mercato:
$54.07M
Reddito:
Utile/perdita netta:
$-55.99M
Rapporto P/E:
-0.9355
EPS:
-2.5013
Flusso di cassa netto:
$-47.60M
1 W Prestazione:
-7.51%
1M Prestazione:
-17.02%
6M Prestazione:
+43.56%
1 anno Prestazione:
+65.96%
Intervallo 1D:
$2.28
$2.49
Intervallo di 1 settimana:
$2.28
$2.69
Portata 52W:
$0.9612
$3.1636
Boundless Bio Inc Stock (BOLD) Company Profile
Nome
Boundless Bio Inc
Settore
Industria
Telefono
(858) 766-9912
Indirizzo
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
2.34 | 54.07M | 0 | -55.99M | -47.60M | -2.5013 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-12-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-04-22 | Iniziato | Guggenheim | Buy |
| 2024-04-22 | Iniziato | Leerink Partners | Outperform |
| 2024-04-22 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Boundless Bio Inc Borsa (BOLD) Ultime notizie
Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Names Senior Leadership Team to Advance Potential Best-in-Class in vivo Base Editing Program for Alpha-1 Antitrypsin Deficiency - The Manila Times
TANG KEVIN C Trims Boundless Bio Inc (BOLD) Stake Amid Volatile Trading - GuruFocus
Boundless Bio (BOLD) Q2 2026 Earnings: Wider-than-Expected Loss of $1.06 per Share Pressures the Stock - dars.gov.et
Boundless Bio (NASDAQ: BOLD) Updates Serapha Merger with 19.99% Ownership Cap and Revised Voting Rules - Kalkine Media
Boundless Bio Amends Merger Agreement with Serapha Bio - TipRanks
Boundless Bio (NASDAQ: BOLD) adds $0.00001 warrants to cap ownership in Serapha deal - Stock Titan
Kevin Tang group trims Boundless Bio (BOLD) stake, returns profit - Stock Titan
2,426,857 Boundless Bio (NASDAQ: BOLD) shares held by Zachary Hornby - Stock Titan
Boundless (BOLD) Financial Update: Profit Per Share Falls Below Its Benchmark in the Reported Period - vinanet.vn
Boundless (BOLD) Session: Climbs 1.40% to $2.90 in the Current Update; Trading Range: Price Remains Between $2.75 Support and $3.04 Resistance on the DayFactor Timing - vinanet.vn
Boundless (BOLD) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Shares Show Limited Movement under the Current SnapshotFiscal Year Earnings - vinanet.vn
Boundless Bio (BOLD): ADAR1 Capital discloses 8.8% beneficial ownership stake - Stock Titan
Boundless Bio (BOLD): Citadel entities and Ken Griffin report 0.6% ownership - Stock Titan
Boundless Bio (BOLD) Edges Up to $2.79 as Stock Holds Tight Trading RangeTriple Bottom - Vinanet
Boundless Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Boundless Bio Inc (BOLD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boundless Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Boundless Bio, Inc. 2Q 2026: Net loss $23.7M, EPS $(1.06) — 10-Q Summary - TradingView
Boundless Bio (Nasdaq: BOLD) plans Serapha merger and dividend - Stock Titan
Boundless Bio (BOLD) Advances 3.57% to $2.90 as Support at $2.75 HoldsBPI Bull Correction - vinanet.vn
Boundless Bio, Inc. Revenue Breakdown – NASDAQ:BOLD - TradingView
Boundless Bio Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Boundless Bio Inc (BOLD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boundless Bio Inc (BOLD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BOLD|Boundless Bio Inc|Price:2.485|Chg%:-0.085 - TradingKey
Boundless Bio Inc (BOLD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boundless Bio Inc (BOLD) Institutional Confidence - TradingKey
Boundless Bio Inc (BOLD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Boundless Bio Inc (BOLD) Balance Sheet - tradingkey.com
BOLD|Boundless Bio Inc|Price:2.580|Chg%:+0.010 - TradingKey
TradingKey - TradingKey
Boundless Bio Inc (BOLD) Income Statement - TradingKey
Boundless Bio Inc (BOLD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boundless Bio Inc (BOLD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tuesday’s insider trading: Healthcare and airline executives make moves - Investing.com
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com South Africa
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com Australia
Major Investor Quietly Boosts Stake in Emerging Biotech Player - TipRanks
Form 4 Boundless Bio Inc For: 21 July By Investing.com - Investing.com South Africa
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com Nigeria
Boundless Bio 10% owner Kevin Tang acquires $11,876 in common shares - Bitget
Boundless Bio director Kevin Tang buys $11,865 in shares - Investing.com
Form 4 Boundless Bio Inc For: 21 July By Investing.com - Investing.com Canada
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com Canada
Boundless Bio 10% owner Kevin Tang acquires $11,876 in common shares - Bitget
Boundless Bio (NASDAQ: BOLD) major Tang Capital holder adds 4,863 shares - Stock Titan
BOLD Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEarnings Quality Analysis - vinanet.vn
Boundless Bio Inc. (BOLD) Q1 2026 Earnings: Small EPS Miss as Pre-Revenue Clinical-Stage Biotech Reports First QuarterAnnual Earnings Summary - vinanet.vn
Boundless Bio Inc. (BOLD) Q1 2026 Earnings: Small EPS Miss as Pre-Revenue Clinical-Stage Biotech Reports First QuarterUpward Estimate Revision - dars.gov.et
Boundless Bio Inc. (BOLD) Holds Near Support After Modest DeclineBuyback Factor - dars.gov.et
Boundless Bio Inc Azioni (BOLD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Boundless Bio Inc Azioni (BOLD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | 10% Owner |
Jul 21 '26 |
Buy |
2.44 |
2,975 |
7,259 |
2,858,935 |
| TANG KEVIN | 10% Owner |
Jul 20 '26 |
Buy |
2.44 |
1,623 |
3,960 |
2,855,960 |
| TANG KEVIN | 10% Owner |
Jul 17 '26 |
Buy |
2.44 |
265 |
647 |
2,854,337 |
| TANG KEVIN | 10% Owner |
Jul 16 '26 |
Buy |
2.44 |
18,491 |
45,118 |
2,854,072 |
| TANG KEVIN | 10% Owner |
Jul 15 '26 |
Buy |
2.44 |
1,600 |
3,904 |
2,835,581 |
| TANG KEVIN | 10% Owner |
Jul 14 '26 |
Buy |
2.43 |
43,878 |
106,624 |
2,833,981 |
| TANG KEVIN | 10% Owner |
Jul 13 '26 |
Buy |
2.42 |
48,211 |
116,671 |
2,790,103 |
| TANG KEVIN | 10% Owner |
Jul 10 '26 |
Buy |
2.43 |
43,367 |
105,382 |
2,741,892 |
| TANG KEVIN | 10% Owner |
Jul 09 '26 |
Buy |
2.48 |
7 |
17 |
2,698,525 |
| TANG KEVIN | 10% Owner |
Jul 08 '26 |
Buy |
2.46 |
14,338 |
35,271 |
2,698,518 |
4.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):